|
|
|
To Be Indexed In: Current
Contents / Clinical Medicine, Science Citation Index Expanded |
|
Home Missions and Scope Editorial Board Instructions for Authors |
|
| Am. J. Biomed. Sci. 2010, 2(2), 98-107; doi: 10.5099/aj100200098 |
Immunogenicity of Nitric Oxide Modified Chromatin and Its Implications
in Systemic Lupus Erythematosus |
|
Sarah Afaq1*
and Rashid Ali2 |
|
1Department of Clinical Biochemistry, College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia |
|
2Department of Biochemistry, College of Medicine, Jawahar Lal Nehru Medical College, Aligarh, India |
|
*Corresponding author |
|
Sarah Afaq,PhD |
|
Assistant Professor |
|
Department of Clinical Biochemistry |
|
College of Medicine |
|
King Khalid University, Abha |
|
Kingdom of Saudi Arabia |
|
PO Box 641 |
|
Email: sarah.afaq@gmail.com |
|
Abstract Freshly isolated chromatin from goat liver, exposed to nitric oxide (generated by the reduction of sodium nitrite with sodium dithionite) caused structural alterations and loss of tertiary structure of chromatin along with strand breaks and base modifications in the DNA of chromatin. The NO-chromatin was highly immunogenic in experimental animals as compared to its native form. Induced antibodies were highly specific for their respective immunogen. However, delineating the antigenic specificity of anti -NO-chromatin antibodies by competition ELISA, multiple cross-reactivity was observed. Anti-NO-chromatin antibodies recognized human blood proteins, modified tyrosine polymers and histones. Moreover, NO modified conformers were better recognized than their native forms. The visual detection of immune complex formation with native and NO-chromatin reiterated preferential binding with modified chromatin. Chromatin modified by nitric oxide presents unique epitopes which may be one of the factors in antigen driven autoimmune response in SLE. Keywords: autoantibodies; chromatin; NO-chromatin; nitric oxide; SLE. Download the full article (PDF)
|
© American Journal of Biomedical Sciences 2007.
All Rights Reserved.